Skip to main content

Table 1 Patient characteristics at baseline

From: Anthracycline-free neoadjuvant therapy induces pathological complete responses by exploiting immune proficiency in HER2+ breast cancer patients

Characteristics

Trastuzumab (T) + paclitaxel (P) (n = 46)

Epirubicin (E) + docetaxel (D) (n = 58)

Median age, years

46

46

 Range

23 - 70

27 - 69

Hormone receptor status

  

 ER+ and PgR+

13

33

 ER+ and PgR-

9

9

 ER- and PgR-

21

15

 ER- and PgR+

3

1

HER2/neu

  

  0-1

 

47

  2+

 

11

CISH/FISH not amplified

/

11

CISH/FISH amplified

/

/

 3+

46

/

Stage distribution

  

 IIA

6

20

 IIB

27

27

 IIIA

12

10

 IIIB

1

1

Histotype

  

 ductal

45

42

 lobular

0

8

 others

1

8

  1. Abbreviations: ER = estrogen receptor; PgR = progesterone receptor; HER2 = human epidermal growth factor receptor-2; CISH = chromogenic in situ hybridization; FISH = fluorescence in situ hybridization.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us